The metabolic syndrome, diabetes, and subclinicalatherosclerosis assessed by coronary calcium
Nathan D. Wong, PhD, FACC ,
Maria G. Sciammarella, MD*,
Donna Polk, MD, MPH*,
Amy Gallagher, MPH*,
Lisa Miranda-Peats, MPH*,
Brian Whitcomb, BS*,
Rory Hachamovitch, MD, FACC*,
John D. Friedman, MD, FACC*,
Sean Hayes, MD* and
Daniel S. Berman, MD, FACC*,*
* Departments of Imaging and Medicine, Cedars-Sinai Medical Center, Los Angeles, USA
Heart Disease Prevention Program, University of California, Irvine, California, USA

View larger version (38K):
[in a new window]
|
Figure 1 Prevalence of coronary artery calcium (CAC) by disease category and gender. Gray bars = neither condition; striped bars = metabolic syndrome (MetS); black bars = diabetes. p = 0.0002 for men and p = 0.02 for women for any CAC and p = 0.01 for men and p = 0.19 for women for CAC 75th percentile across groups (MetS, diabetes, and neither condition).
|
|
|